Valley National to acquire Bluevine for $340 million
Valley National Bancorp (NASDAQ:VLY) agreed to acquire Bluevine for approximately $340 million in a cash-and-stock transaction expected to include about 75% cash and 25% Valley common stock.
Valley National Bancorp (NASDAQ:VLY) agreed to acquire Bluevine for approximately $340 million in a cash-and-stock transaction expected to include about 75% cash and 25% Valley common stock.
Soluna Holdings (NASDAQ:SLNH) amended its agreement with Bitdeer Technologies Group (NASDAQ:BTDR) subsidiary Dory Creek to expand Bitcoin mining operations at Soluna’s Project Kati 1 in South Texas.
TOYO (NASDAQ:TOYO) signed binding U.S. solar module supply agreements worth approximately $240 million with multiple U.S. customers since mid-June 2026.
RedotPay has completed a financial audit as it prepares for a potential US initial public offering.
Arvinas (NASDAQ:ARVN) dosed the first participant in a Phase 1/2 trial of ARV-6723, an investigational oral immuno-oncology candidate designed to degrade HPK1 in adults with advanced solid tumors.
Cosmos Health (NASDAQ:COSM) reported more than $20 million in implied revenue from Cana Laboratories’ contract manufacturing pipeline, based on management estimates over the expected duration of agreements.
Foresight Autonomous Holdings (NASDAQ:FRSX) signed a non-binding term sheet to acquire a 50.01% stake in a company advancing two data center projects in Poland.
TOYO (NASDAQ:TOYO) said it expects positive EBITDA for the second half of 2026 while withholding specific financial guidance due to ongoing U.S. trade and regulatory uncertainty.
Ethereum (ETH) has begun moving towards a 2030 architecture built around cryptographic proofs and decentralised computing.
AbbVie (NYSE:ABBV) received U.S. Food and Drug Administration approval for JUVMO (tavapadon) tablets to treat adults with Parkinson’s disease.
GARANTA JÁ SEU GRAFA EDGE
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade